CAM
WST icon

Chesapeake Asset Management’s West Pharmaceutical WST Stock Holding History

Chesapeake Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$223 – 545
2025
Q1 		$223 Buy
+1
New +$276 ﹤0.01% 508
2024
Q4 		– Sell
-1
Closed -$300 – 579
2024
Q3 		$300 Buy
+1
New +$306 ﹤0.01% 438

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Chesapeake Asset Management's WST Position: Q2 2025 in Review

Chesapeake Asset Management sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 1 share — an estimated $223 sold.

Chesapeake Asset Management first reported a position in WST in Q3 2024 and held it in 2 quarters. The position peaked at $300 in Q3 2024. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Chesapeake Asset Management reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Chesapeake Asset Management sold 1 West Pharmaceutical share in Q2 2025, an estimated $223.
  • Chesapeake Asset Management first reported a position in West Pharmaceutical in Q3 2024 and held it in 2 quarters.
  • Chesapeake Asset Management's West Pharmaceutical position peaked at $300 in Q3 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Chesapeake Asset Management's 13F filing for Q2 2025, filed 15 Oct 2025.